Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QingSong HealthHKSE:02661 -4.59%18 Market Cap is HK$1,218 Mil as of Jul. 25, 2026. GuruFocus rates HKSE:02661 with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 693 Healthcare Providers & Services companies, QingSong Health ranks better than 55.99% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). QingSong Health's share price for the quarter that ended in Dec. 2025 was HK$68.5. QingSong Health's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 206 Mil. Therefore, QingSong Health's market cap for the quarter that ended in Dec. 2025 was HK$14,137 Mil.
QingSong Health's quarterly market cap
stayed the same
from Dec. 2024 (HK$0 Mil) to Jun. 2025 (HK$0 Mil) but then
increased
from Jun. 2025 (HK$0 Mil) to Dec. 2025 (HK$14,137 Mil).
QingSong Health's annual market cap
stayed the same
from Dec. 2023 (HK$0 Mil) to Dec. 2024 (HK$0 Mil) but then
increased
from Dec. 2024 (HK$0 Mil) to Dec. 2025 (HK$14,137 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. QingSong Health's Enterprise Value for Today is HK$114 Mil.
QingSong Health (HKSE:02661) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
QingSong Health Market Cap Related Terms
QingSong Health Market Cap Historical Data
* Premium members only.
The historical data trend for QingSong Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02661 vs VEEV, BTSG, TEM: Market Cap Comparison
For the Health Information Services subindustry, QingSong Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QingSong Health Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, QingSong Health's Market Cap distribution charts can be found below:
* The bar in red indicates where QingSong Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
QingSong Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QingSong Health (HKSE:02661) has a Market Cap of HK$1,218 Mil as of Jul. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on QingSong Health and its competitors. According to the industry distribution chart, QingSong Health ranks #305 out of 693 companies in the Healthcare Providers & Services industry, placing it in the top 44%.
Is QingSong Health's Market Cap too high?
QingSong Health's current Market Cap is HK$1,218 Mil. Based on the distribution chart, QingSong Health ranks #305 out of 693 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, QingSong Health has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does QingSong Health's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, QingSong Health ranks #305 out of 693 companies for Market Cap. This puts QingSong Health in the upper half of its industry. The industry median Market Cap is 103.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 103.69, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on QingSong Health and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 103.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QingSong Health's current Market Cap is HK$1,218 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QingSong Health stock overvalued right now?
QingSong Health (HKSE:02661) has a current Market Cap of HK$1,218 Mil. The current Market Cap is HK$1,218 Mil. QingSong Health's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For QingSong Health (HKSE:02661), the current Market Cap is HK$1,218 Mil as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
QingSong Health Corp is a technology-driven one-stop platform in China, focusing on providing comprehensive health services and health insurance solutions. It offers healthcare-related services, including early disease screening promotion and consultancy, health examinations and consultations, medical appointment services, and the sale of health supplements. It prominently offers health insurance products providing coverage for illness and medical expenses, typically for one year or less. The company also offers critical illness insurance, which provides a lump-sum payment if the policyholder is diagnosed with specified serious illnesses. It derives revenue from the provision of Healthcare-related Services. Geographically, it operates only in China.
18GF Score
Get the complete analysis for HKSE:02661
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02661 has been successfully added to your 
